idazoxan has been researched along with dihydroergotoxine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boulat, O; Maitre, L; Waldmeier, P | 1 |
| De Potter, WP; Saxena, VK; Schoups, AA; Tombeur, K | 1 |
| Kerry, R; Scrutton, MC | 1 |
3 other study(ies) available for idazoxan and dihydroergotoxine
| Article | Year |
|---|---|
3,4-Dihydroxyphenylacetic acid (DOPAC) as an index of noradrenaline turnover: effects of Hydergine and vincamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Cerebellum; Dihydroergotoxine; Dioxanes; Dopamine; Dopamine beta-Hydroxylase; Drug Interactions; Female; Haloperidol; Hippocampus; Idazoxan; Locus Coeruleus; Norepinephrine; Prazosin; Rats; Vincamine | 1990 |
Facilitation of the release of noradrenaline and neuropeptide Y by the alpha 2-adrenoceptor blocking agents idazoxan and hydergine in the dog spleen.
Topics: Adrenergic alpha-Antagonists; Animals; Dihydroergotoxine; Dioxanes; Dioxins; Dogs; Electric Stimulation; Idazoxan; Neuropeptide Y; Norepinephrine; Spleen | 1988 |
Effect of 781094, a new selective alpha-adrenoceptor antagonist, on the aggregatory responses of human blood platelets and on binding of [3H]-dihydroergocryptine to these cells.
Topics: Adrenergic alpha-Antagonists; Blood Platelets; Brimonidine Tartrate; Clonidine; Dihydroergotoxine; Dioxins; Epinephrine; Humans; Idazoxan; Methoxamine; Platelet Aggregation; Quinoxalines; Serotonin; Tritium | 1983 |